Aarkstore Enterprise---johnson & Johnson (jnj) - Financial And Strategic Analysis Review
Johnson & Johnson (J&J) is engaged in the manufacture and sale of a broad range of healthcare products worldwide
. The company focuses on the development of products related to health and well-being. J&J operates through three business segments, namely, Consumer, Pharmaceuticals, and Medical Devices and Diagnostics. The companys Consumer segment offers a wide range of health and personal care products in the beauty, oral care, baby care, womens health and over-the-counter categories. Through its Pharmaceuticals segment, the company focuses on five therapeutic areas, namely, Neuroscience, Cardiovascular Disease and Metabolism, Immunology, Oncology and Infectious Disease.
Table of Contents :
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Johnson & Johnson - Key Facts 5
Johnson & Johnson - Key Employees 6
Johnson & Johnson - Key Employee Biographies 7
Johnson & Johnson - Major Products and Services 8
Johnson & Johnson - History 11
Johnson & Johnson - Company Statement 15
Johnson & Johnson - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Section 2 - Company Analysis 28
Johnson & Johnson - Business Description 28
Business Description - Consumer 28
Consumer - Overview 28
Consumer - Financials 28
Consumer - Market View 29
Consumer - Key Strategies 29
Consumer - Technology 29
Business Description - Medical Devices and Diagnostics 29
Medical Devices and Diagnostics - Overview 29
Medical Devices and Diagnostics - Financials 29
Medical Devices and Diagnostics - Market View 29
Medical Devices and Diagnostics - Key Strategies 30
Medical Devices and Diagnostics - Technology 30
Business Description - Pharmaceutical 30
Pharmaceutical - Overview 30
Pharmaceutical - Financials 30
Pharmaceutical - Market View 30
Pharmaceutical - Key Strategies 31
Pharmaceutical - Technology 31
Johnson & Johnson - SWOT Analysis 32
SWOT Analysis - Overview 32
Johnson & Johnson - Strengths 32
Strength - Strong Liquidity Position 32
Strength - Diversified Product Offerings 32
Strength - Widespread Geographical Presence 32
Strength - Strong In-house Research Capabilities 33
Johnson & Johnson - Weaknesses 33
Weakness - Illegal Promotion of Topamax 33
Weakness - Declining Market Share in the Sector 33
Weakness - Underperforming Pharmaceuticals Segment 33
Weakness - Patent Expiries 34
Weakness - Product Recalls 34
Johnson & Johnson - Opportunities 34
Opportunity - Changing Demographics 34
Opportunity - Growth in the Prevalence of Cancer 34
Opportunity - Global Pharmaceutical Market 35
Opportunity - New Product Launches and Strong Pipeline 35
Opportunity - Strategic Acquisitions 35
Johnson & Johnson - Threats 36
Threat - Increased Pricing Control 36
Threat - Competitive Pressures 36
Threat - Regulatory Requirements 36
Threat - Litigation and Legal Claims 36
Johnson & Johnson - Key Competitors 37
Section 3 - Company Financial Ratios 38
Financial Ratios - Capital Market Ratios 38
Financial Ratios - Annual Ratios 38
Performance Chart 40
Financial Performance 40
Financial Ratios - Interim Ratios 41
Financial Ratios - Ratio Charts 42
Section 4 - Companys Recent Developments 43
Jul 20, 2010: Johnson & Johnson Reports Sales Of $15.33 Billion In Q2 2010 43
Jul 20, 2010: Johnson & Johnson Reports Net Income Of $3.4 billion For Q2 2010 43
Jul 19, 2010: FDA Inspects J&Js Lancaster Manufacturing Unit 43
Jul 19, 2010: Johnson & Johnson Appoints E. L. Davis To Board 43
Jul 19, 2010: Johnson & Johnson Appoints Ian Davis To Board 44
Jul 15, 2010: J&J To Cut 300 Jobs At Pennsylvania Facility 44
Jun 03, 2010: Johnson & Johnson Highlights Growth Strategies For MD&D Segment 44
Apr 20, 2010: J&J Announces Rejection Of Application For Sedasys System By FDA And Provides Updates Of Pipeline Products 46
Apr 20, 2010: J&J Q1 Sales Increase Due To Favourable Currency Exchange Rates 46
Apr 20, 2010: Johnson & Johnson Reports Net Earnings Of $4.5 Billion In Q1 2010 46
Section 5 - Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
For more information please contact :
http://www.aarkstore.com/reports/Johnson-Johnson-JNJ-Financial-and-Strategic-Analysis-Review-62675.html
http://blogs.aarkstore.com/
From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com
by: Aarkstore Enterprise
Aarkstore Enterprise---synthes, Inc. (syst) - Financial And Strategic Analysis Review Aarkstore Enterprise---smith & Nephew Plc (sn.) - Financial And Strategic Analysis Review Aarkstore Enterprise---davita Inc. (dva) - Financial And Strategic Analysis Review Aarkstore Enterprise---edwards Lifesciences Corporation (ew) - Financial And Strategic Analysis Revi Aarkstore Enterprise---fresenius Se (freg) - Financial And Strategic Analysis Review Aarkstore Enterprise---haemonetics Corporation (hae) - Financial And Strategic Analysis Review Aarkstore Enterprise---hanger Orthopedic Group, Inc. (hgr) - Financial And Strategic Analysis Review Strategic Importance Of Seo Company Over Freelancer? Aarkstore Enterprise---hologic, Inc. (holx) - Financial And Strategic Analysis Review Aarkstore Enterprise---aarkstore Enterprise---hospira, Inc. (hsp) - Financial And Strategic Analysis Aarkstore Enterprise---integra Lifesciences Holdings Corporation (iart) - Financial And Strategic An Aarkstore Enterprise---invacare Corporation (ivc) - Financial And Strategic Analysis Review Aarkstore Enterprise---steris Corporation (ste) - Financial And Strategic Analysis Review
Aarkstore Enterprise---johnson & Johnson (jnj) - Financial And Strategic Analysis Review Anaheim